ECDEYO Trademark

Trademark Overview


On Wednesday, March 2, 2022, a trademark application was filed for ECDEYO with the United States Patent and Trademark Office. The USPTO has given the ECDEYO trademark a serial number of 97291156. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, August 5, 2024. This trademark is owned by Amgen Inc.. The ECDEYO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
ecdeyo

General Information


Serial Number97291156
Word MarkECDEYO
Filing DateWednesday, March 2, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Wednesday, December 14, 2022ASSIGNED TO EXAMINER
Saturday, March 5, 2022NEW APPLICATION ENTERED
Monday, March 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 6, 2023SOU EXTENSION 1 FILED
Wednesday, September 6, 2023SOU EXTENSION 1 GRANTED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 2 FILED
Wednesday, January 24, 2024SOU EXTENSION 2 GRANTED
Monday, August 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU EXTENSION 3 GRANTED
Monday, August 5, 2024SOU EXTENSION 3 FILED